{"id":"intermediate-dose-dalteparin","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Thrombocytopenia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Elevated transaminases"}]},"_chembl":{"chemblId":"CHEMBL1201460","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dalteparin binds to and potentiates antithrombin III, a natural anticoagulant, leading to inactivation of activated clotting factors, particularly factor Xa and to a lesser extent thrombin. This prevents thrombus formation and propagation. Intermediate dosing provides a balance between anticoagulant efficacy and bleeding risk for specific clinical scenarios.","oneSentence":"Dalteparin is a low-molecular-weight heparin that inhibits blood coagulation by enhancing the activity of antithrombin III against factor Xa and thrombin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:20.460Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Thromboembolism prophylaxis and treatment"},{"name":"Acute coronary syndrome"},{"name":"Venous thromboembolism prevention and treatment"}]},"trialDetails":[{"nctId":"NCT06667999","phase":"PHASE4","title":"The Intensive Care Platform Trial","status":"RECRUITING","sponsor":"Anders Perner","startDate":"2025-06-26","conditions":"Intensive Care Patients, Intensive Care Unit Patients, Critical Illness","enrollment":10000},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT07384598","phase":"NA","title":"Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure Treated or Not With Continuous Veno-veinous Hemofiltration.","status":"NOT_YET_RECRUITING","sponsor":"Clinique Saint Pierre Ottignies","startDate":"2026-02-01","conditions":"Thromboprophylaxis, Critical Illness, Intensive Care (ICU)","enrollment":60},{"nctId":"NCT05848713","phase":"PHASE3","title":"AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-10-10","conditions":"Community-acquired Pneumonia","enrollment":4000},{"nctId":"NCT06381661","phase":"PHASE2","title":"Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05-01","conditions":"Sepsis","enrollment":2000},{"nctId":"NCT06581965","phase":"PHASE4","title":"inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2024-11-11","conditions":"Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism","enrollment":10078},{"nctId":"NCT05625932","phase":"PHASE3","title":"TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Galician Research Group on Digestive Tumors","startDate":"2023-03-02","conditions":"Colorectal Cancer Metastatic, Thromboembolism","enrollment":232},{"nctId":"NCT05990894","phase":"","title":"Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2020-07-01","conditions":"Cerebral Venous Thrombosis","enrollment":170},{"nctId":"NCT06845423","phase":"PHASE4","title":"Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-05-16","conditions":"Venous Thromboembolism (VTE), Post Partum Women","enrollment":2400},{"nctId":"NCT06453876","phase":"PHASE3","title":"Percutaneous Embolectomy, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism","status":"NOT_YET_RECRUITING","sponsor":"Jesper Kjaergaard","startDate":"2025-06-01","conditions":"Pulmonary Embolism","enrollment":210},{"nctId":"NCT06862726","phase":"PHASE4","title":"Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation","status":"ENROLLING_BY_INVITATION","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2024-12-01","conditions":"Non Valvular Atrial Fibrillation","enrollment":120},{"nctId":"NCT04367831","phase":"PHASE4","title":"Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-05-02","conditions":"COVID-19, Venous Thromboses, Arterial Thrombosis","enrollment":94},{"nctId":"NCT04427098","phase":"PHASE2","title":"Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2020-05-22","conditions":"COVID-19","enrollment":301},{"nctId":"NCT04088292","phase":"PHASE3","title":"Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2019-06-06","conditions":"Pulmonary Embolism","enrollment":210},{"nctId":"NCT02464969","phase":"PHASE4","title":"Apixaban for the Acute Treatment of Venous Thromboembolism in Children","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2015-11-22","conditions":"Venous Thromboembolism","enrollment":229},{"nctId":"NCT06662253","phase":"PHASE2, PHASE3","title":"Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"Alexandre Tran","startDate":"2025-01","conditions":"Venous Thromboembolism (VTE), Trauma Related Injuries","enrollment":150},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04483960","phase":"PHASE3","title":"Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Melbourne","startDate":"2020-07-28","conditions":"SARS-CoV-2 Infection (COVID-19)","enrollment":2200},{"nctId":"NCT06153394","phase":"PHASE3","title":"Prolonged Hypercoagulability Following Major Liver Resection for Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2024-06-01","conditions":"Hepatic Disease, Surgery-Complications, Hypercoagulability","enrollment":50},{"nctId":"NCT03659708","phase":"NA","title":"Pregnancy and Risk of Venous Thromboembolism","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2021-01-22","conditions":"Thromboembolism, Pregnancy","enrollment":600},{"nctId":"NCT02604238","phase":"PHASE3","title":"Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism","status":"WITHDRAWN","sponsor":"Azienda U.S.L. 1 di Massa e Carrara","startDate":"2016-03","conditions":"Pulmonary Embolism","enrollment":""},{"nctId":"NCT04406389","phase":"PHASE4","title":"Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2020-10-13","conditions":"COVID-19","enrollment":14},{"nctId":"NCT04646655","phase":"PHASE3","title":"Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19","status":"COMPLETED","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2020-07-27","conditions":"Covid19, Thrombosis","enrollment":142},{"nctId":"NCT05541978","phase":"","title":"Thrombosis in Patients With Multiple Myeloma in an University Medical Center","status":"COMPLETED","sponsor":"Catalina Codreanu","startDate":"2022-09-01","conditions":"Multiple Myeloma, Venous Thromboembolism, Arterial Thromboembolism","enrollment":140},{"nctId":"NCT05901337","phase":"NA","title":"Cupping Therapy on Immune System in Post Covid -19","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-03-07","conditions":"Covid-19 Patients","enrollment":76},{"nctId":"NCT04072068","phase":"PHASE4","title":"Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy","status":"COMPLETED","sponsor":"Gruppo Oncologico Italiano di Ricerca Clinica","startDate":"2019-06-27","conditions":"Thromboembolism, Cancer","enrollment":150},{"nctId":"NCT05493163","phase":"PHASE4","title":"Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2022-10-19","conditions":"Pulmonary Embolism","enrollment":558},{"nctId":"NCT05512702","phase":"","title":"Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism","status":"UNKNOWN","sponsor":"Ege University","startDate":"2022-06-03","conditions":"Pulmonary Embolism","enrollment":100},{"nctId":"NCT01828697","phase":"PHASE4","title":"Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-04-24","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1110},{"nctId":"NCT04377997","phase":"PHASE2","title":"Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2020-05-15","conditions":"Cardiovascular Diseases, COVID-19","enrollment":300},{"nctId":"NCT05172115","phase":"PHASE3","title":"Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE","status":"TERMINATED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2018-12-22","conditions":"Pulmonary Embolism, Pulmonary Thromboembolisms, Embolism, Pulmonary","enrollment":94},{"nctId":"NCT04401293","phase":"PHASE3","title":"Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2020-04-26","conditions":"Sars-CoV2, COVID","enrollment":257},{"nctId":"NCT05036824","phase":"","title":"Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"University Hospital of Patras","startDate":"2021-10-01","conditions":"Covid19, Hospitalization","enrollment":300},{"nctId":"NCT04158973","phase":"NA","title":"CHIPs-VTE Study in Hospitalized Patients With Lung Cancer","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2021-12-01","conditions":"Venous Thromboembolic Disease, Pulmonary Embolism, Deep Venous Thrombosis","enrollment":3200},{"nctId":"NCT04394377","phase":"PHASE4","title":"Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial","status":"COMPLETED","sponsor":"Brazilian Clinical Research Institute","startDate":"2020-06-21","conditions":"Coronavirus Infection","enrollment":615},{"nctId":"NCT00362947","phase":"PHASE3","title":"Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2006-08","conditions":"Thrombophlebitis","enrollment":664},{"nctId":"NCT04700670","phase":"","title":"Evaluation of the Effect of Dextran Sulphate on Anti-Xa Activities Measured","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2020-01-16","conditions":"Unfractionated Heparin Treatment","enrollment":164},{"nctId":"NCT04520620","phase":"PHASE4","title":"Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention","status":"WITHDRAWN","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2020-05-02","conditions":"Sars-CoV2","enrollment":""},{"nctId":"NCT00986154","phase":"PHASE3","title":"Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2009-10","conditions":"Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)","enrollment":8292},{"nctId":"NCT01662908","phase":"PHASE2","title":"A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2012-08","conditions":"Deep Vein Thrombosis, Venous Thrombosis","enrollment":85},{"nctId":"NCT01589393","phase":"NA","title":"OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)","status":"COMPLETED","sponsor":"McMaster University","startDate":"2010-09","conditions":"Traumatic Intracranial Haemorrhage","enrollment":52},{"nctId":"NCT03426982","phase":"PHASE4","title":"Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring","status":"UNKNOWN","sponsor":"Wuhan Asia Heart Hospital","startDate":"2018-03-01","conditions":"Myocardial Infarction, Venous Thromboembolism, Stroke","enrollment":700},{"nctId":"NCT01542762","phase":"NA","title":"Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-03","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500},{"nctId":"NCT01542723","phase":"NA","title":"Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-05","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500},{"nctId":"NCT02091479","phase":"PHASE3","title":"Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2013-01","conditions":"Major hæmorrhage","enrollment":14},{"nctId":"NCT02696330","phase":"PHASE4","title":"Comparison Between Effect of Enoxaparin and Clopidogrel on Improving Pregnancy Rate in ICSI","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2015-09","conditions":"Female , Infertility","enrollment":150},{"nctId":"NCT01356992","phase":"PHASE3","title":"Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation","status":"TERMINATED","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2012-07","conditions":"Non ST Segment Elevation Myocardial Infarction, Unstable Angina","enrollment":62},{"nctId":"NCT02260908","phase":"NA","title":"OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage - Pilot Study","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2014-10","conditions":"Traumatic Intracranial Haemorrhage","enrollment":300},{"nctId":"NCT01164046","phase":"PHASE3","title":"Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism","status":"TERMINATED","sponsor":"University Medical Center Groningen","startDate":"2010-08","conditions":"Venous Thromboembolism, Neoplasms","enrollment":56},{"nctId":"NCT02295150","phase":"PHASE4","title":"Prophylaxis of Venous Thromboembolism After Bariatric Surgery","status":"UNKNOWN","sponsor":"Rijnstate Hospital","startDate":"2013-03","conditions":"Morbid Obesity, Thromboembolism, Bypass Complications","enrollment":50},{"nctId":"NCT02240927","phase":"NA","title":"Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves","status":"UNKNOWN","sponsor":"Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital","startDate":"2010-01","conditions":"Pregnancy, Heart; Complications, Valve, Prosthesis","enrollment":40},{"nctId":"NCT00113932","phase":"PHASE2","title":"UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2003-12","conditions":"Multiple Myeloma","enrollment":140},{"nctId":"NCT01210755","phase":"PHASE4","title":"Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2010-11","conditions":"Venous Thromboembolism","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["dalteparin","Fragmin"],"phase":"marketed","status":"active","brandName":"Intermediate dose dalteparin","genericName":"Intermediate dose dalteparin","companyName":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","companyId":"academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dalteparin is a low-molecular-weight heparin that inhibits blood coagulation by enhancing the activity of antithrombin III against factor Xa and thrombin. Used for Thromboembolism prophylaxis and treatment, Acute coronary syndrome, Venous thromboembolism prevention and treatment.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}